Company intelligence / Profile preview

Beijing Advanced Medical Technologies

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

AMT Medical has developed fully bioresorbable coronary and peripheral stents using its proprietary 3D-MAP technology. Its lead products AMSorb® and PeriSorb® are currently in randomized controlled trials in China. The company's approach offers improved efficiency and lower cost compared to traditional laser-cutting methods for bioresorbable vascular stents.

Therapeutic areas: GastroenterologyNeurologyCardiovascular
Modalities: DeviceBioresorbable stent system (medical device)Balloon dilatation catheter (medical device)
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Beijing Advanced Medical Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Advanced Medical Technologies.

Explore the full profile